(Q34502982)

2 August 2017

title

Immunosuppression promotes reovirus therapy of colorectal liver metastases (English)

1 reference

2 August 2017

1 reference

1 reference

Smakman N

1

1 reference

2 August 2017

van der Bilt JD

2

1 reference

2 August 2017

van den Wollenberg DJ

3

1 reference

2 August 2017

Hoeben RC

4

1 reference

2 August 2017

Borel Rinkes IH

5

1 reference

2 August 2017

Kranenburg O

6

1 reference

2 August 2017

publication date

10 March 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

13

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

815-818

1 reference

Replication-selective oncolytic viruses in the treatment of cancer.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Reovirus receptors and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Not all viruses are bad guys: the case for reovirus in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Validation of bioluminescence imaging of colorectal liver metastases in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

Morbidity in immunosuppressed (SCID/NOD) mice treated with reovirus (dearing 3) as an anti-cancer biotherapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700949

21 January 2018

Identifiers

DOI

10.1038/SJ.CGT.7700949

1 reference

Dimensions Publication ID

2 August 2017

1042737484

0 references

1 reference